The expression and significance of stem cell transcription factor Sox2 in lung carcinoma

Chinese Journal of Lung Cancer

Volumn 16, Issue 11, 2013, Pages 591-595

  Xu, Wei ^a,b   Wei, Yun Yan ^a   Tan, Yao Xi ^a   Cheng, Steven Yan ^c   Wu, Jian Qing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cells; Lung neoplasms; Sox2; Sox2 self antibody

Indexed keywords

SOX2 ANTIBODY; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; SOXB1 TRANSCRIPTION FACTORS;

EID: 84887748779     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2013.11.05     Document Type: Article

References (16)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin, 2013, 63(1): 11-30.
2. Adachi K, Suemori H, Yasuda SY, et al. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells, 2010, 15(5): 455-470.
3. Wang Z, Oron E, Nelson B, et al. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell, 2012, 10(4): 440-454.
4. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature, 2007, 448(7151): 313-317.
5. Drilon A, Rekhtman N, Ladanyi M, et al. Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy. Lancet Oncol, 2012, 13(10): e418-e426.
6. Sholl LM, Barletta JA, Yeap BY, et al. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol, 2010, 34(8): 1193-1198.
7. Cai YR, Zhang HQ, Zhang ZD, et al. Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma. Oncol Lett, 2011, 2(2): 257-264.
8. Nakatsugawa M, Takahashi A, Hirohashi Y, et al. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest, 2011, 91(12): 1796-1804.
9. Maddison P, Thorpe A, Silcocks P, et al. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer. Lung Cancer, 2010, 70(3): 335-339.
10. Sun Y, Zhang R, Wang M, et al. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma. Cancer Epidemiol Biomarkers Prev, 2012, 21(11): 2043-2047.
11. Chen S, Xu Y, Chen Y, et al. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One, 2012, 7(5): e36326.
12. Rudin CM, Durinck S, Stawiski EW, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet, 2012, 44(10): 1111-1116.
13. Pietanza MC, Ladanyi M. Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet, 2012, 44(10): 1074-1075.
14. Chou YT, Lee CC, Hsiao SH, et al. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells, 2013 Aug 13, doi: 10.1002/stem.1518, [Epub ahead of print].
15. Xu C, Xie D, Yu SC, et al. β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. Cancer Res, 2013, 73(10): 3181-3189.
16. Ruan J, Wei B, Xu Z, et al. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer. Med Oncol, 2013, 30(1): 445.